ACRP CCRC Exam Prep 2025. GENUINE 2025
COMPLETE QUESTIONS AND ANSWERS. (100%
VERIFIED UPDATE)
Adverse Drug Reaction (ADR)-CORRECT ANS>>In the pre-approval clinical
experience with a new medicinal product or its new usages, particularly
as the therapeutic dose(s) may not be established: all noxious and
unintended responses to a medicinal product related to any dose should
be considered adverse drug reactions.
Adverse Event (AE)-CORRECT ANS>>Any untoward medical occurrence in
a patient or clinical investigation subject administered a pharmaceutical
product and which does not necessarily have a causal relationship with
this treatment.
Applicable Regulatory Requirement(s)-CORRECT ANS>>Any law(s) and
regulation(s) addressing the conduct of clinical trials of investigational
products.
Approval (in relation to Institutional Review Boards)-CORRECT ANS>>The
affirmative decision of the IRB that the clinical trial has been reviewed
and may be conducted at the institution site within the constraints set
forth by the IRB, the institution, Good Clinical Practice (GCP), and the
applicable regulatory requirements.
Audit-CORRECT ANS>>A systematic and independent examination of trial
related activities and documents to determine whether the evaluated
trial related activities were conducted, and the data were recorded,
analyzed and accurately reported according to the protocol, sponsor’s
standard operating procedures (SOPs), Good Clinical Practice (GCP), and
the applicable regulatory requirement(s).
Audit Certificate-CORRECT ANS>>A declaration of confirmation by the
auditor that an audit has taken place.
Audit Report-CORRECT ANS>>A written evaluation by the sponsor's
auditor of the results of the audit.
Audit Trail-CORRECT ANS>>Documentation that allows reconstruction of
the course of events.
,Blinding/Masking-CORRECT ANS>>A procedure in which one or more
parties to the trial are kept unaware of the treatment assignment(s).
Single-blinding-CORRECT ANS>>usually refers to the subject(s) being
unaware
Double- blinding-CORRECT ANS>>usually refers to the subject(s),
investigator(s), monitor, and, in some cases, data analyst(s) being
unaware of the treatment assignment(s).
Case Report Form (CRF)-CORRECT ANS>>A printed, optical, or electronic
document designed to record all of the protocol required information to
be reported to the sponsor on each trial subject.
Clinical Trial/Study-CORRECT ANS>>Any investigation in human subjects
intended to discover or verify the clinical, pharmacological and/or other
pharmacodynamic effects of an investigational product(s), and/or to
identify any adverse reactions to an investigational product(s), and/or to
study absorption, distribution, metabolism, and excretion of an
investigational product(s) with the object of ascertaining its safety and/or
efficacy.
Clinical Trial/Study Report-CORRECT ANS>>A written description of a
trial/study of any therapeutic, prophylactic, or diagnostic agent
conducted in human subjects, in which the clinical and statistical
description, presentations, and analyses are fully integrated into a single
report
Comparator (Product)-CORRECT ANS>>An investigational or marketed
product (i.e., active control), or placebo, used as a reference in a clinical
trial.
Compliance (in relation to trials)-CORRECT ANS>>Adherence to all the
trial-related requirements, Good Clinical Practice (GCP) requirements,
and the applicable regulatory requirements.
Confidentiality-CORRECT ANS>>Prevention of disclosure, to other than
authorized individuals, of a sponsor’s proprietary information or of a
subject's identity.
Contract-CORRECT ANS>>A written, dated, and signed agreement
, between two or more involved parties that sets out any arrangements on
delegation and distribution of tasks and obligations and, if appropriate,
on financial matters.
Coordinating Committee-CORRECT ANS>>A committee that a sponsor
may organize to coordinate the conduct of a multicenter trial.
Coordinating Investigator-CORRECT ANS>>An investigator assigned the
responsibility for the coordination of investigators at different centers
participating in a multicenter trial.
Contract Research Organization (CRO)-CORRECT ANS>>A person or an
organization (commercial, academic, or other) contracted by the sponsor
to perform one or more of a sponsor's trial- related duties and functions.
Direct Access-CORRECT ANS>>Permission to examine, analyze, verify,
and reproduce any records and reports that are important to evaluation of
a clinical trial.
Documentation-CORRECT ANS>>All records, in any form (including, but
not limited to, written, electronic, magnetic, and optical records, and
scans, x-rays, and electrocardiograms) that describe or record the
methods, conduct, and/or results of a trial, the factors affecting a trial,
and the actions taken.
Essential Documents-CORRECT ANS>>Documents which individually and
collectively permit evaluation of the conduct of a study and the quality of
the data produced
Good Clinical Practice (GCP)-CORRECT ANS>>A standard for the design,
conduct, performance, monitoring, auditing, recording, analyses, and
reporting of clinical trials that provides assurance that
COMPLETE QUESTIONS AND ANSWERS. (100%
VERIFIED UPDATE)
Adverse Drug Reaction (ADR)-CORRECT ANS>>In the pre-approval clinical
experience with a new medicinal product or its new usages, particularly
as the therapeutic dose(s) may not be established: all noxious and
unintended responses to a medicinal product related to any dose should
be considered adverse drug reactions.
Adverse Event (AE)-CORRECT ANS>>Any untoward medical occurrence in
a patient or clinical investigation subject administered a pharmaceutical
product and which does not necessarily have a causal relationship with
this treatment.
Applicable Regulatory Requirement(s)-CORRECT ANS>>Any law(s) and
regulation(s) addressing the conduct of clinical trials of investigational
products.
Approval (in relation to Institutional Review Boards)-CORRECT ANS>>The
affirmative decision of the IRB that the clinical trial has been reviewed
and may be conducted at the institution site within the constraints set
forth by the IRB, the institution, Good Clinical Practice (GCP), and the
applicable regulatory requirements.
Audit-CORRECT ANS>>A systematic and independent examination of trial
related activities and documents to determine whether the evaluated
trial related activities were conducted, and the data were recorded,
analyzed and accurately reported according to the protocol, sponsor’s
standard operating procedures (SOPs), Good Clinical Practice (GCP), and
the applicable regulatory requirement(s).
Audit Certificate-CORRECT ANS>>A declaration of confirmation by the
auditor that an audit has taken place.
Audit Report-CORRECT ANS>>A written evaluation by the sponsor's
auditor of the results of the audit.
Audit Trail-CORRECT ANS>>Documentation that allows reconstruction of
the course of events.
,Blinding/Masking-CORRECT ANS>>A procedure in which one or more
parties to the trial are kept unaware of the treatment assignment(s).
Single-blinding-CORRECT ANS>>usually refers to the subject(s) being
unaware
Double- blinding-CORRECT ANS>>usually refers to the subject(s),
investigator(s), monitor, and, in some cases, data analyst(s) being
unaware of the treatment assignment(s).
Case Report Form (CRF)-CORRECT ANS>>A printed, optical, or electronic
document designed to record all of the protocol required information to
be reported to the sponsor on each trial subject.
Clinical Trial/Study-CORRECT ANS>>Any investigation in human subjects
intended to discover or verify the clinical, pharmacological and/or other
pharmacodynamic effects of an investigational product(s), and/or to
identify any adverse reactions to an investigational product(s), and/or to
study absorption, distribution, metabolism, and excretion of an
investigational product(s) with the object of ascertaining its safety and/or
efficacy.
Clinical Trial/Study Report-CORRECT ANS>>A written description of a
trial/study of any therapeutic, prophylactic, or diagnostic agent
conducted in human subjects, in which the clinical and statistical
description, presentations, and analyses are fully integrated into a single
report
Comparator (Product)-CORRECT ANS>>An investigational or marketed
product (i.e., active control), or placebo, used as a reference in a clinical
trial.
Compliance (in relation to trials)-CORRECT ANS>>Adherence to all the
trial-related requirements, Good Clinical Practice (GCP) requirements,
and the applicable regulatory requirements.
Confidentiality-CORRECT ANS>>Prevention of disclosure, to other than
authorized individuals, of a sponsor’s proprietary information or of a
subject's identity.
Contract-CORRECT ANS>>A written, dated, and signed agreement
, between two or more involved parties that sets out any arrangements on
delegation and distribution of tasks and obligations and, if appropriate,
on financial matters.
Coordinating Committee-CORRECT ANS>>A committee that a sponsor
may organize to coordinate the conduct of a multicenter trial.
Coordinating Investigator-CORRECT ANS>>An investigator assigned the
responsibility for the coordination of investigators at different centers
participating in a multicenter trial.
Contract Research Organization (CRO)-CORRECT ANS>>A person or an
organization (commercial, academic, or other) contracted by the sponsor
to perform one or more of a sponsor's trial- related duties and functions.
Direct Access-CORRECT ANS>>Permission to examine, analyze, verify,
and reproduce any records and reports that are important to evaluation of
a clinical trial.
Documentation-CORRECT ANS>>All records, in any form (including, but
not limited to, written, electronic, magnetic, and optical records, and
scans, x-rays, and electrocardiograms) that describe or record the
methods, conduct, and/or results of a trial, the factors affecting a trial,
and the actions taken.
Essential Documents-CORRECT ANS>>Documents which individually and
collectively permit evaluation of the conduct of a study and the quality of
the data produced
Good Clinical Practice (GCP)-CORRECT ANS>>A standard for the design,
conduct, performance, monitoring, auditing, recording, analyses, and
reporting of clinical trials that provides assurance that
